Apr 5 |
Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
|
Mar 22 |
Dianthus Therapeutics Insiders Added US$2.05m Of Stock To Their Holdings
|
Mar 21 |
Dianthus Therapeutics reports FY results
|
Mar 21 |
Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q4 and FY2023 Financial Results
|
Dec 12 |
Here's Why We're Watching Dianthus Therapeutics' (NASDAQ:DNTH) Cash Burn Situation
|
Nov 22 |
Antibody Player Dianthus Therapeutics Has Potential Amid Active M&A Landscape in Complement-Focused Firms: Analyst
|
Nov 22 |
Wedbush starts Dianthus at outperform, sees DNTH103 as well-positioned
|
Nov 9 |
Magenta Therapeutics GAAP EPS of -$3.78
|